IIM Bangalore alumnus Khet Singh Rajpurohit named in Forbes 30 Under 30 Asia 2025

PGP 2021 graduate and Co-founder of ClaimBuddy recognized for his contribution to building tech-driven health insurance solutions in India
15 May, 2025, Bengaluru: In another compelling testament to the caliber of entrepreneurial talent nurtured at IIMB, an alumnus of the Post Graduate Programme batch of 2021- Khet Singh Rajpurohit, Co-founder, ClaimBuddy, has been featured in the Forbes 30 Under 30 Asia 2025 list.
What began as a campus-stage initiative under the mentorship of IIMB’s startup incubator and accelerator hub, NSRCEL, during his second year at the Institute, has since scaled into a growing Insurtech enterprise. Today, ClaimBuddy operates as a single-point solution for health insurance claim assistance, serving over 250 hospitals across seven cities.
Under the leadership of Khet and co-founder Ajit Kumar Patel, ClaimBuddy has built digital infrastructure that has facilitated claim processing for more than 35,000 patients.
IIM Bangalore alumnus Khet Singh Rajpurohit named in Forbes 30 Under 30 Asia 2025
PGP 2021 graduate and Co-founder of ClaimBuddy recognized for his contribution to building tech-driven health insurance solutions in India
15 May, 2025, Bengaluru: In another compelling testament to the caliber of entrepreneurial talent nurtured at IIMB, an alumnus of the Post Graduate Programme batch of 2021- Khet Singh Rajpurohit, Co-founder, ClaimBuddy, has been featured in the Forbes 30 Under 30 Asia 2025 list.
What began as a campus-stage initiative under the mentorship of IIMB’s startup incubator and accelerator hub, NSRCEL, during his second year at the Institute, has since scaled into a growing Insurtech enterprise. Today, ClaimBuddy operates as a single-point solution for health insurance claim assistance, serving over 250 hospitals across seven cities.
Under the leadership of Khet and co-founder Ajit Kumar Patel, ClaimBuddy has built digital infrastructure that has facilitated claim processing for more than 35,000 patients.